Penn Medicine launched national component of global registry to track exposures and outcomes among providers who intubate
On Apr. 15, 2020, a team at the Perelman School of Medicine at the University of Pennsylvania launched…
Bellicum completed sale of Houston facility to MD Anderson for $15 million
On Apr. 15, 2020, Bellicum Pharma announced closing of the sale of its Houston facility to The University…
Microneedle coronavirus vaccine triggered immune response in mice
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
Gilead announced $20 million philanthropic fund to support nonprofit organizations impacted by the COVID-19 crisis
On Apr. 8, 2020, Gilead Sciences announced the creation of the global Gilead CARES (COVID-19 Acute Relief and…
Arizona COVID-19 Genomics Union to track the virus
On Apr. 8, 2020, TGen, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern…
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
Rice University established COVID-19 research fund
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
Minneapolis Heart Institute Foundation engaged in COVID-19 STEMI research study
On Apr. 6, 2020, the Minneapolis Heart Institute Foundation (MHIF) announced it was serving as the international coordinating…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Non-Profit Research | Therapeutics
Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
Map revealed hidden U.S. hotspots of Coronavirus infection at the country level
On Apr. 2, 2020, a University of Chicago team announced that it had mapped confirmed COVID-19 infections per…
Mayo Clinic in Florida expanded specimen testing and processing capabilities for COVID-19
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
COVID-19 Therapeutics Accelerator awarded $20 million in initial grants to fund clinical trials
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…
TGen, a genomic first responder, ramped up testing against COVID-19 coronavirus
On Mar. 30, 2020, the Translational Genomics Research Institute (TGen) announced that it had joined the world-wide effort…
Bellerophon Therapeutics announced first patient treated with INOpulse inhaled nitric oxide therapy for COVID-19
On Mar. 30, 2020, Bellerophon Therapeutics announced that expanded access treatment with the INOpulse inhaled nitric oxide system…
Broad Institute’s CLIA-certified testing center began processing COVID-19 patient samples
On Mar. 26, 2020, working in partnership with the Commonwealth of Massachusetts, Massachusetts State Public Health Laboratory, and…
COVID-19 first target of new AI research consortium
On Mar. 26, 2020, the University of California, Berkeley, and University of Illinois at Urbana-Champaign were selected a…
Amyris launched hand sanitizer and receives initial positive result for vaccine adjuvant
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
UC Health launched clinical trials to assess antiviral drug for COVID-19
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator
On Mar. 25, 2020, NASA’s Jet Propulsion Laboratory (JPL) in Southern California announced that after receiving more than…
Biotechnology | COVID-19 | Diagnostics | Medical Device | Medicine | NIH | Non-Profit Research | Therapeutics
National Library of Medicine expanded access to coronavirus literature through PubMed Central
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
Oxford University launched world’s first COVID-19 government response tracker
On Mar. 25, 2020, University of Oxford researchers announced they had launched the world’s first COVID-19 government response…
Oxford University COVID-19 study showed that Wuhan travel restrictions prevented wider disease spread
On Mar. 25, 2020, a mobility and epidemiological study from a global consortium of researchers, led by the…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 research
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
Penn’s Perelman School of Medicine launched Coronavirus research center
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
City of Hope researchers developing COVID-19 vaccine
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
New COVID-19 assay adapted to run on T2 Biosystems’ FDA-cleared T2Dx Instrument
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
Resverlogix invited collaborations for use of Apabetalone in trials and studies to Combat spread of COVID-19
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…